Allergy Relief 24hr
NDC Package 73226-001-00
Package Information
Allergy Relief 24hr is adults 65 years of age and older■ ask a doctoradults and children 12-64 years of age ■ take 1 tablet (5 mg) once daily in the evening ■ do not take more than 1 tablet (5 mg) in 24 hours ■ ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms children 6-11 years of age■ take ½ tablet (2.5 mg) once daily in the evening ■ do not take more than ½ tablet (2.5 mg) in 24 hours children under 6 years of age■ do not useconsumers with kidney disease■ do not use(Note: Age ranges are bolded in the draft container labeling for tablet bottle). Marketed by Vitesse Pharma Llc, this product is identified by NDC 73226-001 and is authorized under FDA application ANDA211551.
Identification & Billing
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG Oral Tablet
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 73226 - Vitesse Pharma Llc
- 73226-001 - Allergy Relief 24hr
- 73226-001-00 - 40 BAG in 1 CARTON / 2500 TABLET in 1 BAG
- 73226-001 - Allergy Relief 24hr
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 73226-001-00 identifies a specific commercial package of 40 bag in 1 carton / 2500 tablet in 1 bag of Allergy Relief 24hr, labeled by Vitesse Pharma Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Vitesse Pharma Llc on July 02, 2019. The current certification is valid through December 31, 2022.
How is this Vitesse Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 73226000100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.